XIV International Congress on Parkinson's Disease
Helsinki, Finland, July 28th - August 1st, 2001

Essential tremor

• Neurotransmitter Abnormalities in ET Brain, SSRI Treatment in Model of PD

Multiple System Atrophy

• MSA Diagnosis, Lamotrigine Trial

Parkinson's Disease: Etiology and Pathogenesis

• Parkin: Localization, Pathologic Basis of Mutation
• Ultrasound Abnormalities in the Substantia Nigra
• PD Genetics: Cuban Kindred Without Known Mutations; Haploinsufficiency of Parkin
• Gene Microarrays Track Neurodegeneration, Protection

Parkinson's Disease: Pharmacologic Treatment

• High-Dose Pergolide Can Substitute for Levodopa
• Dyskinesias Correlate with Decreased Mental Health and Increase Health Costs
• Genotypic Basis of Tolcapone Sensitivity
• Neurotransmitter Abnormalities in ET Brain, SSRI Treatment in Model of PD
• Sublingual Atropine for Sialorrhea
• Levodopa Pharmacokinetics
• No Acceleration of Dyskinesias After Ropinirole Monotherapy
• Rasagiline for Early PD
• High-Dose Ropinirole
• Cabergoline Tolerability in Elderly Patients

Parkinson's Disease: Surgery

• Experimental Surgeries
• Thalamotomy vs. Thalamic Stimulation for Tremor
• Depression in PD: Prevalence and Correlates
• Depression in PD: Treatment
• Sexual Function, Caregiver Stress in PD
• Sleep Disorders and Sleep Attacks
• Ultrasound Abnormalities in the Substantia Nigra
• Neurotransmitter Abnormalities in ET Brain, SSRI Treatment in Model of PD

Meeting Reports Menu